Identification of rictor as a novel substrate of Polo-like kinase 1

Tian Shao1, Xiaoqi Liu

  • 1a Department of Biochemistry ; Purdue University ; West Lafayette , IN USA.

Insights

Polo-like kinase 1 (Plk1) phosphorylates Rictor, a key mTORC2 component, at Ser1162. This phosphorylation regulates the mSin1.5 isoform, potentially revealing a new Plk1-mTORC2 signaling pathway beyond cell cycle control.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Signal Transduction

Background:

  • Polo-like kinase 1 (Plk1) is a critical regulator of mitosis.
  • Emerging evidence suggests Plk1's functions extend beyond the cell cycle.
  • The mammalian target of rapamycin (mTOR) pathway controls cell growth and proliferation.

Purpose of the Study:

  • To investigate the potential link between Plk1 and the mTOR pathway.
  • To identify new substrates of Plk1 involved in cellular signaling.
  • To elucidate the role of Rictor phosphorylation by Plk1.

Main Methods:

  • In vitro and in vivo phosphorylation assays.
  • Site-directed mutagenesis to create unphosphorylatable Rictor mutants (S1162A).
  • Analysis of mTOR pathway components and isoforms.

Main Results:

  • Rictor, a component of mTORC2, was identified as a novel Plk1 substrate.
  • Plk1 phosphorylates Rictor at Ser1162.
  • The S1162A Rictor mutant did not affect canonical PI3K-mTOR signaling but led to elevated mSin1.5 levels.
  • Elevated mSin1.5 suggests a role in stress signaling.

Conclusions:

  • Plk1 directly phosphorylates Rictor at Ser1162.
  • This phosphorylation event may regulate a novel mTORC2-mediated signaling pathway involving mSin1.5.
  • Plk1's role may extend to stress response pathways via mTORC2 regulation.